As of 2026-06-23, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (34.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.71 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -232.4%.
The range of the Relative Valuation is (36.80) - (35.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.2x - 39.0x | 34.6x |
| Forward P/E multiples | 24.3x - 33.1x | 28.6x |
| Fair Price | (36.80) - (35.68) | (34.05) |
| Upside | -243.2% - -238.8% | -232.4% |
| Date | P/E |
| 2026-06-22 | -23.86 |
| 2026-06-18 | -23.76 |
| 2026-06-17 | -23.62 |
| 2026-06-16 | -23.31 |
| 2026-06-15 | -24.06 |
| 2026-06-12 | -22.62 |
| 2026-06-11 | -24.96 |
| 2026-06-10 | -23.19 |
| 2026-06-09 | -23.92 |
| 2026-06-08 | -23.06 |
| 2026-06-05 | -23.51 |
| 2026-06-04 | -25.00 |
| 2026-06-03 | -23.19 |
| 2026-06-02 | -22.54 |
| 2026-06-01 | -22.90 |
| 2026-05-29 | -23.20 |
| 2026-05-28 | -22.96 |
| 2026-05-27 | -22.94 |
| 2026-05-26 | -24.13 |
| 2026-05-22 | -24.03 |
| 2026-05-21 | -23.72 |
| 2026-05-20 | -24.22 |
| 2026-05-19 | -23.16 |
| 2026-05-18 | -23.77 |
| 2026-05-15 | -22.79 |
| 2026-05-14 | -25.15 |
| 2026-05-13 | -22.24 |
| 2026-05-12 | -21.63 |
| 2026-05-11 | -17.71 |
| 2026-05-08 | -17.71 |
| 2026-05-07 | -18.18 |
| 2026-05-06 | -17.83 |
| 2026-05-05 | -17.31 |
| 2026-05-04 | -18.59 |
| 2026-05-01 | -19.33 |
| 2026-04-30 | -19.65 |
| 2026-04-29 | -18.76 |
| 2026-04-28 | -20.26 |
| 2026-04-27 | -21.02 |
| 2026-04-24 | -21.37 |
| 2026-04-23 | -22.51 |
| 2026-04-22 | -22.67 |
| 2026-04-21 | -22.26 |
| 2026-04-20 | -22.03 |
| 2026-04-17 | -21.72 |
| 2026-04-16 | -19.04 |
| 2026-04-15 | -18.23 |
| 2026-04-14 | -18.67 |
| 2026-04-13 | -17.56 |
| 2026-04-10 | -17.33 |